Glass House Brands (GLAS) Interest & Investment Income (2020 - 2025)

Glass House Brands' (GLAS) quarterly Interest & Investment Income came in at $576000.0 in Q4 2025, up 1694217.65% on a QoQ basis from -$34.0 in Q1 2024.

Glass House Brands (GLAS) Interest & Investment Income (2020 - 2025) Analysis & Trends

Glass House Brands (GLAS) has 6 years of Interest & Investment Income data on file, last reported at $576000.0 in Q4 2025.

  • On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $576000.0 in Q4 2025; TTM through Dec 2025 was $35.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $288000.0, changed N/A from the prior year.
  • Interest & Investment Income for Q4 2025 stood at $576000.0, up from -$34.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for GLAS reached as high as $35.1 million in Q4 2023 and fell as low as -$32.2 billion in Q2 2021.
  • Historically, Interest & Investment Income has averaged -$3.8 billion across 5 years, with a median of -$35.0 in 2022.
  • Across the five-year window, Interest & Investment Income plunged 49.8% in 2022 and jumped 61488.48% in 2023, its largest moves.
  • Year by year, Interest & Investment Income stood at $113502.0 in 2021, then tumbled by 49.8% to $56975.0 in 2022, then soared by 61488.48% to $35.1 million in 2023, then plunged by 100.0% to -$34.0 in 2024, then jumped by 1694217.65% to $576000.0 in 2025.
  • Per Business Quant data, the three most recent Interest & Investment Income figures were $576000.0 in Q4 2025, -$34.0 in Q1 2024, and $35.1 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 576,000.00
Mar 31, 2024 -34.00
Dec 31, 2023 35.09 Mn
Sep 30, 2023 -34.00
Jun 30, 2023 -35.00 Mn
Mar 31, 2023 -45,000.00
Dec 31, 2022 56,975.00
Sep 30, 2022 -35.00
Jun 30, 2022 -472.00 Mn
Dec 31, 2021 113,502.00
Sep 30, 2021 -16.44 Bn
Jun 30, 2021 -32.22 Bn
Mar 31, 2021 -16,086.00
Mar 31, 2020 -98,341.00